Elixicure CBD-Infused Pain Relief Product Receives FDA Certification
SANTA ANA, Calif., Jan. 29, 2020 /PRNewswire/ — Elixicure’s Over-The-Counter Drug Registration has been Certified by the U.S. Food and Drug Administration (FDA) for its Elixicure CBD-Infused Pain Relief products following a successful year-long process, announced Elixicure Chief of Business Development Yaniv Kotler. This marks the very first, and currently only, Over-The-Counter (OTC) Topical drug with Cannabidiol (CBD) to be registered and certified to date.
Elixicure CBD-Infused Pain Relief Product Receives FDA Certification
I recently came across a mention on Instagram that Elixicure was the “first and only FDA approved over-the-counter CBD product,” and I was stopped dead in my tracks wondering how I could have missed such a monumental moment in cannabis history. I immediately began researching. First, the FDA website. No announcements of a new CBD approval or about Elixicure or its labeler, Honest Globe. Then my most trusted cannabis news sources. Nothing. I moved to a google search and found: an online retail site…
Elixicure adds Don Donovan to the Corporate Advisory Board and as Chief Marketing Officer
Don is an inventor, data scientist, and author of “The Right to Succeed™, A marketing Approach Guaranteed to Deliver.” Don worked at Proctor & Gamble as general management, client relations, and head of Consumer Packaged Goods for over 20 years. In 2005 he founded and became the CEO of Baker Street Solutions – a marketing consulting firm. He is Baker Street’s “Discovery” guru! Don’s vision for how consumer behavior is translated into predictive modeling is the basis for his extraordinary career.